Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 1/2 2

Status

Completed 3Withdrawn 1Terminated 1

Sponsor Class

INDUSTRY 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5Plasma cell 1Lymphoid 1Gynecologic 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 26Lung Neoplasms 23Neoplasms 7Small Cell Lung Carcinoma 5Neoplasm Metastasis 4Mesothelioma 4Breast Neoplasms 4Vomiting 3Nausea 3Triple Negative Breast Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Kidney Neoplasms 2Head and Neck Neoplasms 2Brain Neoplasms 2Stomach Neoplasms 1Radiation Pneumonitis 1Postoperative Complications 1Pain, Postoperative 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Mesothelioma, Malignant 1Melanoma 1Malnutrition 1Lymphoma 1Lung Diseases, Interstitial 1Liver Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1

Interventions

Etoposide 156Carboplatin 146Cisplatin 106Topotecan 76durvalumab 52atezolizumab 51Irinotecan 45pembrolizumab 39Paclitaxel 34Nivolumab 33Radiotherapy 31PM 01183 25Drug Therapy 24anlotinib 23Gemcitabine 21apatinib 19Ipilimumab 18Docetaxel 17Temozolomide 16Platinum 16Radiosurgery 15Pemetrexed 14toripalimab 13tislelizumab 13olaparib 13Magnetic Resonance Spectroscopy 13Bevacizumab 13rovalpituzumab tesirine 11amrubicin 11Specimen Handling 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Small Cell Lung Carcinoma × Dexamethasone × Thoracic × Clear all
NCT03554473 2025-05-09

M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
37 enrolled 19 charts
Thoracic

Lung Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT03033511 2021-07-29

MERU

AbbVie

Phase 3 Terminated
748 enrolled 13 charts
Thoracic

Neoplasms, Small Cell Lung Carcinoma

NCT03061812 2021-02-23

TAHOE

AbbVie

Phase 3 Completed
444 enrolled 16 charts
Thoracic

Neoplasm Metastasis, Small Cell Lung Carcinoma

NCT03334487 2018-12-26

Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer

AbbVie

Phase 3 Withdrawn
Thoracic

Neoplasms, Small Cell Lung Carcinoma

NCT00531284 2017-08-15

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

Amgen

Phase 1/2 Completed
184 enrolled 36 charts
GenitourinaryGynecologicLymphoidPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Lymphoma, Multiple Myeloma, Ovarian Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡